Introduction: Brain tumors are heterogenous group of neoplasms with annual incidence of 5 to 10 per 100000 population in India. Classification of tumors is an art of pathology to distinguish between benign and malignant lesions on histological ground. But histological diagnosis of brain tumors is not always straight forward due to not only overlap in morphological features among different categories of tumors but also due to divergent differentiation within the same tumor. So, application of immunohistochemical markers has become necessary for an exact diagnosis and subtyping. . Based on histopathological examination of Hematoxylin and Eosin stained sections, total of 226 brain tumors were diagnosed. Out of which, immunohistochemical markers were applied on 50 cases for accurate diagnosis and grading. Results: In the present study, most common histological tumor type was astrocytoma followed by meningioma. Out of 226 cases, 176cases were diagnosed by histopathology alone while 50 cases were sent for IHC. Immunohistochemical staining was done on 42 problematic cases to reach the final diagnosis and on 36 cases for grading. Conclusion: The present study show that histopathological examination is a vital tool for diagnosis and grading in most of the tumors but IHC play an important role in difficult cases where diagnosis and grading is not possible only on histological basis.
Introduction
The annual incidence of brain tumors ranges from 10 to 17 per 100000 population and majority of these tumors are primary tumors, only one fourth to one half are metastatic. 1 About 10% primary brain tumors occurs in pediatric population with most frequent being astrocytomas, medulloblastomas. 2 Histological diagnosis of brain tumors is not easy due to overlap in morphological features among different categories, divergent differentiation within the same tumor and non-neoplastic lesion can also mimic tumor. 3 Hence, in spite of clinical data, imaging techniques and preoperative findings, application of immune histochemical markers has become necessary for an exact diagnosis and subtyping. In last two decades www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i3.186 diagnostic neuropathology benefited by incorporation of immunohistochemistry (IHC). 4 The principle of IHC was known since 1930s, but first IHC study was reported in1942. When Coons et al used FITC-labelled antibodies to identify pneumococcal antigen in infected tissue. The fundamental concept behind IHC is the demonstration of antigen within tissue sections by means of specific antibodies. Once Ag-Ab binding occurs, it is visible by light microscopy or flourochromes by ultraviolet light. 5 Recently our knowledge regarding the genetics of central nervous system tumors has expanded, hence newer antibodies or molecular markers are continuously being developed, which can be used in IHC. 6 The approach to diagnosis relies principally on histological evaluation of H&E stained sections with incorporation of smear preparations, histochemical stains, electron microscopy, and immunohistochemichal preparation as supplemental aid in diagnosis. 7 So, the present study was planned to determine the proportion of occurrence of types of brain tumors and to access the efficacy and utility of immunohistochemistry in the diagnosis and grading of brain tumors.
Materials and Methods
It was a hospital based cross sectional observational study, carried out in Department of Pathology, SMS Medical College, Jaipur (Rajasthan) from June 2016 to June 2017 after obtaining approval from institutional ethics committee. Specimens of brain tumors were received from Department of Neurosurgery of our institute. Total of 226 specimens were received which were classified according to "WHO classification for Central Nervous System Tumors 2007". Demographic, clinical, imaging and histological data of all cases were noted in a predesigned and semi-structured performa. The tissue was fixed in 10% formalin for histopathological examination. Then paraffin embedded blocks were made in the usual manner and thin sections of 5 microns were cut by using a microtome. Sections are stained by hematoxylin & eosin stains and histological and immunohistochemical analysis was performed to diagnose and classify various brain tumors according to the World Health Organization (2007) . IHC was performed on problematic cases where final diagnosis was not given on H&E sections. Using 3µm thick sections on Poly-l-lysin coated slides, antigen retrieval was done using decloaking chamber in citrate buffer at PH 6. Required markers were used for antigen detection. Autolysed specimens were excluded.
Results
In the present study, total 226 brain tumors were diagnosed. Astrocytic tumors were found in highest frequency (42.48%) followed by meningioma (19.91%), schawannoma (7.52%) and oligodendroglial tumors (6.65%) [ Table-1 ]. About 68.14% brain tumors were located in supratentorial region while only 31.86% were located in infratentorial region. The highest age incidence of all brain tumors were observed in age group 31-40 years (23.45%) followed by 41-50 years (19.47%), 21-30 years (15.93%) and 51-60 years (12.39%). Overall M:F ratio observed was 1.26:1. Highest astrocytic tumors were observed in age group 21-30 years (21.88%) followed by 31-40 years (17.71%), 41-50 years (15.63%) and 51-60 years (14.58%). Maximum astrocytic tumors were of grade IV with M:F ratio 2:1. Highest oligodendroglioma were observed in age group 4 th (33.33%) and 5 th (53.33%) decade of age with M:F ratio of 2:1. Out of 226 brain tuomrs, 3 cases of mixed glioma (all among males), 7 cases of ependymal tumors (M:F ratio 2:1), 2 cases of choroid plexus tumors (M:F ratio 1:1) and 2 cases of neuronal and mixed neuronal-glial tuomrs (M:F ratio 1:1) were found. 70%meduloblastoma were observed in 1 st decade of life with male-female ratio of 1.5:1 while about 65% schawannoma were found among 4 th and 5 th decade of life with M:F ratio of 1.3:1. 45 meningeal tumors were observed making 19.91% of brain tumors. Meningiomas were highest in 4 th to 6 th decade of life with M:F ratio of 1:2. The most common variant was transitional meningioma followed by meningothelial meningioma. Peak incidence of craniopharyngioma was observed in 1 st decade of life (55.55%) with M:F ratio of 2:1. Out of 226 cases, 176 cases were diagnosed histopathologically while immunohistochemistry was done for 42 problematic cases to reach the final diagnosis and on 36 cases for grading [Table- 2]. 8 . In the present study, 68.14% tumors were supratentorial and 31.86% were infratentorial which is almost same as mentioned in Robin's pathologic basis of disease (J Neurosurg 21;201-206) 10 . Peak incidence of brain tumors were noted in fourth decade of life which is similar to Venugopal Madabhushi et al (2015) 11 whereas Sajeeb Mondal et al (2016) 8 noted peak incidence in 5 th decade. Among 96 cases (42.48%) of astrocytoma, grade IV astrocytoma was most common subtype which is consistent with Sajeeb Mondal et al (2016) 8 . All cases were located supratentorially which is consistent with David N Louis et al (2016) 12 . Oligodendroglioma comprised of 15 cases (6.64%) cases with M:F ratio 2:1. This is close to the result of Jayanti Mehta et al (2017) 13 who reported the incidence of oligodendroglioma as 7.9%, M:F ratio 2:1. Ependymoma comprised of 3.10% which is consistent with the study of Yong-Hyun Chai (2017) 14 (3-9%) . Medulloblastoma In present study schwannoma comprised 17 cases (7.52%) and M:F ratio was 1.12:1, most cases were seen in 4 th and 5 th decade. All these findings were consistent with David N Louis et al (2016) 12 . 45 cases (19.91%) of meningioma were found in present study and M:F ratio was 1:2, which is very much consistent with Bondy M et al (1996) 16 . Incidence of craniopharyngioma were 3.98% in the present study, which is consistent with Niki Karavitaki et al (2006) 17 (2-5%). About 2.66% cases of lymphomas were found which was consistent with the Uwe Schlegal et al 2009 18 (3%). 3.98% tumors were metastatic brain tumors, which was consistent with Kenneth E Livingston et al (1948) 19 . Out of 226 cases 50 cases were referred to IHC section for grading and diagnosis. For 19 cases of astrocytoma, immunohistochemistry was used. Final diagnosis was made by correlating histopathological and immune histochemical findings. MIB-LI was done on all 19 cases for grading and on 11 cases GFAP was also applied for confirmation of glial differentiation. On reviewing literatures it was found that GFAP marker define neoplastic astroglial differentiation (Fletcher DMCristopher 4 th edition) 20 . MIB-LI in grade I (pilocytic astrocytoma) was typically<1% (David N Louis et al 2007) 21 but can vary from 0 to 3.9% (Giannini C et al 1999) 22 which was consistent with our study (MIB-L1 3%). MIB-LI value varied from <1%-4% for grade II, 8%-10% for grade III, 15%-60% for grade IV astrocytoma which was consistent with the study of David N Louis et al (2016) 12 (grade II MIB-LI is upto 4%, for grade III 5-10% and for grade IV>10%) but MIB-LI has overlapped values so cannot be used alone as diagnostic factor, it should be used with combination of established histological criterias (Johannessen et al 2006) 23 . In one case of oligodendroglioma GFAP was positive and MIB-LI was 80%. Glial protein may be focally present in oligodendroglioma due to presence of mature reactive astrocytes. Minigemistocytes are also positive for GFAP and these are frequently present in anaplastic oligodendrogliomas (David N Louis et al 2007 21 , Y Nakagawa et al 1986 24 ). MIB-LI is usually >5% for anaplastic oligodendroglioma (David N Louis et al 2016 12 ). 3 cases of oligoastrocytoma were positive for GFAP and MIB-LI value varied from 3-4%.GFAP is expressed in astroglial component and variably expressed by oligodendroglial component(David N Louis et al 2007 21 and Rama Goyal et al 2015 25 ) and average value of MIB-LI is less than 6% for grade II(David N Louis et al 2016 12 ). 2 cases of Ependymoma were positive for GFAP and EMA. In one case with high MIB-LI (15%), close follow up was advised. Ependymoma show immunoreactivity for GFAP and EMA (Kunishio K et al 1991 26 ). MIB LI <4% has greater survival and >5% has poor survival (Prayson RA et al 1999) 27 .One case of central neurocytoma was positive for synaptophysin, Neu N and GFAP and MIB-LI was 2%. Central neurocytomas express neuronal markers synaptophysin, Neu N and also GFAP (You H et al 2005) 28 MIB-L1 labeling index is usually low(< 2%) (Rades D et al 2004) 29 . 7 cases medulloblastomas showed positivity for synaptophysin, NSE, Neu N and vimentin. MIB labeling index was range from 40-80%. In 5 cases EMA and GFAP were applied to rule out ependymoma, which were negative. Medulloblastoma show immunoreactivity for synaptophysin, NSE, vimentin. MIB-LI is generally >20% (Schiffer D et al 1994 30 ).
Out of 45 cases of meningioma only 4 cases were sent to IHC section. EMA, S-100, vimentin were positive in different cases. MIB was applied on 2 cases, values varied from <1% to 7%. Meningioma show EMA, vimentin and S-100 (JM Theaker et al 1986 31 ) and MIB-LI >4% have increased recurrence rate (David N Louis et al 2016 12 ). One case of hemangioblastoma was positive for inhibin and S-100. According to Shih Ming Jung et al (2005) 33 hemangioblastoma show immunoreactivity for inhibin whereas study of Frank TS et al (1989) 34 show that few cases may be immunoreactivity for S-100 and GFAP (negative in our case). 2 cases of hemangiopericytoma were positive for CD34 and vimentin which was consistent with the study of Middleton LP et al 1998 35 . 6 cases of round cell tumors were positive for CD20, Bcl-2, Bcl-6, MUM-1 and PAX-5 and reported as diffuse large B cell lymphoma. In two cases MIB-LI was 75%. According to Kristopher D M Fletcher 4 th edition 20 B cell lineage is positive for CD 20and PAX-5.DLBCL show immunoreactivity for Bcl-6 (60%), Bcl-2 (50%), CD 10 (40%) and MUM-1. Mean MIB LI for DLBCL is 55%. One case of germ cell tumor was positive for PLAP and CD117. According to YupingGao et al (2002) 36 PLAP, CD117 were highly expressed in seminomas/ germinomas. Out of 3 cases of metastatic adenocarcinoma 1 case was positive for PSA and AMACR which was consistent with the study of Hameed et al (2005) 37 and another 2 cases were positive for EMA, TTF-1 and CK 7 which were consistent with Sushila Jaiswal 2016 6 .
Conclusion
The present study showed that histopathological examination is vital tool for diagnosis and grading in most of the tumors but immunohistochemistry plays an important role in difficult cases where diagnosis and grading is not possible only on histological basis.
